Now showing items 21-30 of 47
Epidemiology and outcomes of Clostridium difficile infection in allogeneic hematopoietic cell and lung transplant recipients
(Wiley Periodicals, Inc., 2018-04)
BackgroundClostridium difficile infection (CDI) is a common complication of lung and allogeneic hematopoietic cell (HCT) transplant, but the epidemiology and outcomes of CDI after transplant are poorly described.MethodsWe ...
Biopsy-proven adenoviral diarrhea responding to low-dose cidofovir
(Blackwell Publishing Inc, 2008-10)
We present a case of diarrhea secondary to biopsy-proven adenovirus (ADV) infection after autologous peripheral hematopoietic stem cell transplant for multiple myeloma. The patient had a negative plasma polymerase chain ...
Effect of metronidazole use on tacrolimus concentrations in transplant patients treated for Clostridium difficile
(Wiley Periodicals, Inc.Truven Health Analytics, 2016-10)
BackgroundTwo case reports suggest that metronidazole treatment for Clostridium difficile infections (CDI) increases tacrolimus (TAC) trough levels. The primary objective of this study was to determine the clinical ...
Multicenter evaluation of efficacy and safety of lowâ dose versus highâ dose valganciclovir for prevention of cytomegalovirus disease in donor and recipient positive (D+/R+) renal transplant recipients
(Wiley Periodicals, Inc., 2016-12)
BackgroundThe cytomegalovirus (CMV) donorâ positive/recipientâ positive (D+/R+) population is the largest proportion of renal transplant recipients (RTR). Guidelines for prevention of CMV in the intermediateâ risk D+/R+ ...
False‐positive Aspergillus galactomannan assay in solid organ transplant recipients with histoplasmosis
(Wiley Periodicals, Inc., 2012-04)
A multicenter evaluation of hepatitis B reactivation with and without antiviral prophylaxis after kidney transplantation
(UpToDateWiley Periodicals, Inc., 2022-02)
BackgroundHepatitis B virus (HBV) reactivation in hepatitis B surface antigen (HBsAg)- negative and hepatitis B core antibody (anti- HBc)- positive kidney transplant recipients ranges between 1.4% and 9.6%. Limited ...
Oropharyngeal candidiasis outcomes in renal transplant recipients receiving nystatin versus no antifungal prophylaxis
(Wiley Periodicals, Inc., 2021-06)
ObjectiveTo compare the incidence of oropharyngeal candidiasis (OC), or thrush, in renal transplant recipients receiving nystatin versus no antifungal prophylaxis.MethodsThis was a single‐center, retrospective, non‐inferiority ...
Increasing net immunosuppression after BK polyoma virus infection
(Wiley Periodicals, Inc., 2021-04)
BackgroundReducing immunosuppression can effectively treat BK viremia (BKV) and BK nephropathy, but has been associated with increased risks for acute rejection and development of donor- specific antibodies (DSA). To date ...
Acquired hypogammaglobulinemia and pathogen‐specific antibody depletion after solid organ transplantation in human immunodeficiency virus infection: A brief report
(Wiley Periodicals, Inc., 2019-12)
Hypogammaglobulinemia (HGG) frequently occurs in recipients after types of (SOT). The incidence and significance of HGG in HIV+ recipients of SOT are just being explored. We reported that 12% of the recipients in the SOT ...
Macrolide‐resistant Mycoplasma pneumoniae pneumonia in transplantation: Increasingly typical?
(Wiley Periodicals, Inc.ASM Press, 2020-10)
Mycoplasma pneumoniae is one of the most common bacterial causes of pneumonia. Macrolide‐resistant M pneumoniae (MRMP) was documented in 7.5% of isolates in the United States. Resistance portends poor outcomes to macrolide ...